These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2682980)

  • 1. Double-blind, placebo-controlled study of OM-8980 in rheumatoid arthritis.
    Hauzeur JP; Appelboom T
    Rheumatol Int; 1989; 9(2):71-6. PubMed ID: 2682980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
    Vischer TL
    Ann Rheum Dis; 1988 Jul; 47(7):582-7. PubMed ID: 3041924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OM-8980 in rheumatoid arthritis: a 6-month double blind placebo controlled multicenter study.
    Brackertz D; Vischer TL
    J Rheumatol; 1989 Jan; 16(1):19-23. PubMed ID: 2654391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OM-8980 and D-penicillamine in the treatment of rheumatoid arthritis. A 12-month double-blind randomized study.
    Verstraeten A; Sileghem A; Dequeker J
    Scand J Rheumatol; 1990; 19(6):422-31. PubMed ID: 2259898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis.
    Vischer TL
    Clin Rheumatol; 1990 Sep; 9(3):356-61. PubMed ID: 2261735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longterm treatment of rheumatoid arthritis with OM-8980. A retrospective study.
    Rosenthal M; Bahous I; Ambrosini G
    J Rheumatol; 1991 Dec; 18(12):1790-3. PubMed ID: 1795313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 6-month randomized dose range study of OM-8980 in rheumatoid arthritis.
    Müller-Fassbender HR
    Br J Rheumatol; 1993 Aug; 32(8):746-50. PubMed ID: 8348280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiprilose hydrochloride for rheumatoid arthritis.
    Riskin WG; Gillings DB; Scarlett JA
    Ann Intern Med; 1989 Sep; 111(6):455-65. PubMed ID: 2672925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis.
    Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():87-93. PubMed ID: 3898298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
    Tilley BC; Alarcón GS; Heyse SP; Trentham DE; Neuner R; Kaplan DA; Clegg DO; Leisen JC; Buckley L; Cooper SM; Duncan H; Pillemer SR; Tuttleman M; Fowler SE
    Ann Intern Med; 1995 Jan; 122(2):81-9. PubMed ID: 7993000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study.
    van Rijthoven AW; Dijkmans BA; Goei The HS; Hermans J; Montnor-Beckers ZL; Jacobs PC; Cats A
    Ann Rheum Dis; 1986 Sep; 45(9):726-31. PubMed ID: 3532966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study.
    Am J Med; 1995 Feb; 98(2):156-68. PubMed ID: 7847432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study.
    Schaad UB; Mütterlein R; Goffin H;
    Chest; 2002 Dec; 122(6):2042-9. PubMed ID: 12475845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auranofin versus placebo in the treatment of rheumatoid arthritis.
    Wenger ME; Alexander S; Bland JH; Blechman WJ
    Am J Med; 1983 Dec; 75(6A):123-7. PubMed ID: 6419593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.
    Hansen TM; Kryger P; Elling H; Haar D; Kreutzfeldt M; Ingeman-Nielsen MW; Olsson AT; Pedersen C; Rahbek A; Tvede N
    BMJ; 1990 Aug; 301(6746):268-70. PubMed ID: 2202458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ileum-targeted steroid therapy in rheumatoid arthritis: double-blind, placebo-controlled trial of controlled-release budesonide.
    Sheldon P
    Rheumatol Int; 2003 Jul; 23(4):154-8. PubMed ID: 12856138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
    Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
    Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis.
    Wendling D; Racadot E; Wijdenes J; Sibilia J; Flipo RM; Cantagrel A; Miossec P; Eschard JP; Macro M; Bertin P; Lioté F; Debiais F; Juvin R; Le Goff P; Masson C
    J Rheumatol; 1998 Aug; 25(8):1457-61. PubMed ID: 9712083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timegadine: more than a non-steroidal for the treatment of rheumatoid arthritis. A controlled, double-blind study.
    Egsmose C; Lund B; Andersen RB
    Scand J Rheumatol; 1988; 17(2):103-11. PubMed ID: 3291099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoprofen versus indomethacin and placebo. A double-blind three-way cross-over trial in rheumatoid arthritis.
    Nissilä M; Jalava S; Groppi W
    Eur J Rheumatol Inflamm; 1981; 4(1):74-8. PubMed ID: 7042365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.